Molecular Partners AG Sponsored ADR MOLN

4.22 (0.08) (1.86%) as of 25 Sep
Market cap
$160.5M
P/E
0.0×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 1.59 0.00 0.00 —
P/S ratio
0.00 0.00 0.00 0.00 0.00 58.15 1.13 17.43 28.64 —
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 1.92 0.00 0.00 —
P/Operating CF
(17.34) (17.34) (17.34) (17.34) (17.34) (29.21) (15.24) (8.02) (11.48) —
P/B ratio
5.47 5.47 5.47 5.47 5.47 5.25 0.91 0.70 1.00 —
Price to Tangible BV
5.49 5.49 5.49 5.49 5.49 5.27 0.91 0.70 1.01 —
EV/Sales
0.00 0.00 0.00 0.00 0.00 44.45 (0.19) (9.12) (1.43) —
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.09 0.12 —
EV/Operating CF
0.00 0.00 0.00 0.00 0.00 (3.02) (0.32) 1.09 0.12 —
EV/FCF
0.00 0.00 0.00 0.00 0.00 (3.02) (0.33) 1.07 0.12 —
Quick Ratio
11.49 10.06 4.08 3.40 3.06 3.38 14.50 13.10 14.07 8.61
Current Ratio
11.52 10.08 4.16 3.49 3.08 3.50 14.77 13.35 14.31 8.79
Net Debt/EBITDA
9.80 5.71 2.71 2.71 3.13 2.18 (2.09) 3.18 2.54 1.66
Debt/Assets
0.00% 0.00% 0.00% 2.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.14 0.23 0.13 0.16 0.06 0.05 0.86 0.03 0.03 0.00
Operating CF/Net income
1.88 1.55 1.13 (0.01) 0.46 1.43 1.01 0.95 1.10 0.83
Capex/Depreciation
0.00 0.00 0.00 0.00 (0.58) (0.51) (0.59) (0.33) (0.31) (0.33)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(14.47%) (20.57%) (35.54%) (50.08%) (78.68%) (60.23%) 67.89% (31.17%) (34.35%) (57.72%)
ROA
(11.13%) (28.75%) (47.74%) (28.07%) (43.44%) (35.88%) 53.26% (27.85%) (30.62%) (49.07%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(11.06%) (19.52%) (31.41%) (48.03%) (48.46%) (50.84%) 48.16% (33.74%) (36.59%) (67.69%)
Average Days of Receivables
13.37 21.03 1,819.36 36.92 110.82 959.83 1.96 101.28 170.16 0.00
Research and Development Expense of Revenue
148.43% 182.02% 360.98% 203.16% 0.00% 0.00% 0.00% 0.00% 0.00% —
Selling, General and Administrative Expense of Revenue
31.41% 41.37% 91.38% 64.58% 124.09% 178.94% 11.73% 275.11% 353.78% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 31.38% 41.88% 2.68% 73.98% 82.60% 0.00%
Graham Net Nets
0.17 0.17 0.17 0.17 0.17 0.18 1.07 1.39 0.97 —
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 25.40 0.00 0.00 —
Earnings Yield
(11.74%) (11.74%) (11.74%) (11.74%) (11.74%) (11.74%) 62.97% (50.84%) (38.11%) —
Free Cash Flow Yield
0.00% 0.00% 0.00% 0.00% 0.00% (25.33%) 52.07% (48.75%) (42.14%) —
Revenue per Share
1.11 0.84 0.50 0.98 0.40 0.34 6.12 0.24 0.17 0.00
Operating CF per Share
(1.68) (1.66) (2.01) 0.01 (1.24) (3.21) 3.83 (2.01) (1.98) (1.66)
Capex per Share
0.00 0.00 0.00 0.00 (0.07) (0.05) (0.05) (0.03) (0.02) (0.02)
Free Cash Flow per Share
(1.68) (1.66) (2.01) 0.01 (1.31) (3.26) 3.78 (2.03) (2.00) (1.68)
Cash per Share
8.65 5.94 4.77 4.58 7.41 4.69 8.04 6.35 4.99 3.01
Shareholders Equity per Share
6.52 4.91 4.42 2.61 4.57 3.79 7.59 6.00 4.73 2.60
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
6.52 4.91 4.42 2.61 4.57 3.79 7.59 6.00 4.73 2.60
Free Cash Flow
(34.37) (40.21) (42.59) 0.21 (32.71) (100.94) 122.76 (66.63) (68.12) (62.73)
Working Capital
162.54 131.00 118.83 73.52 128.14 128.37 248.88 198.32 163.00 103.62
Capital Expenditures
(1.08) (0.51) (0.88) (1.92) (1.80) (1.43) (1.48) (0.90) (0.82) (0.86)
Net Current Asset Value
130.64 117.17 91.70 50.64 103.98 108.11 238.56 189.96 156.06 90.65
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.05 0.12 —
Capex to Sales
0.00 0.00 0.00 0.00 0.18 0.13 0.01 0.11 0.15 0.00
Net Profit Margin
(80.78%) (127.05%) (357.66%) (178.03%) (671.70%) (653.93%) 62.16% (880.71%) (1,087.39%) 0.00%
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 2.00 0.00 0.00 —
Other line items
Depreciation/Fixed assets
0.44 0.61 0.64 0.58 0.31 0.31 0.33 0.43 0.56 0.41
Cash ROIC
(11.88%) (16.01%) (22.66%) (2.66%) (13.66%) (41.27%) 22.99% (17.80%) (21.80%) (32.58%)
Accounts Receivable Turnover
22.54 20.38 0.39 0.77 3.87 0.69 13.64 4.83 2.35 0.00
Accounts Payable Turnover
0.00 1.34 0.00 0.00 14.42 8.53 10.30 29.18 30.75 22.86
Inventory Turnover
— 0.00 — — 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
0.00 228.24 0.00 0.00 37.92 48.40 15.41 9.94 13.96 16.05
Days of Inventory on Hand
— 0.00 — — 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
1.00 1.00 26.92 27.40 2.58 15.54 14.57 1.62 2.40 2.42
Average Payables
0.87 0.87 1.44 2.12 4.15 7.15 5.17 1.86 1.80 2.12
Average Assets
163.93 90.24 79.16 133.25 154.11 194.48 231.87 247.88 200.51 151.66
Average Common Equity
126.12 126.12 106.34 74.69 85.09 115.87 181.91 221.48 178.70 128.92

Fold the line items

Columns are period end dates